- Ray Moynihan
- London
Questioned repeatedly about the effect of the drug industry on doctors' prescribing, medical education, scientific research, and drug evaluation, government officials told a parliamentary inquiry last week that there was no evidence of unhealthy influence.
Four senior officials from the Department of Health and one from the Department of Trade and Industry were giving evidence at the first public hearing of the far reaching inquiry of the House of Commons Health Committee into the industry's influence on the health system.
Committee chairman David Hinchliffe, who is soon to retire, told the BMJ that a key reason for the inquiry was the …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Re: Sir Karl Popper, swans, and the general practitioner
Published 6 February 2012
The TBAS cost effectiveness is not proven beyond the experimental contest
Published 6 February 2012
Re: Why legislation is necessary for my health reforms
Published 6 February 2012
Re: Dual renin-angiotensin system blockade
Published 6 February 2012
Re: Why legislation is necessary for my health reforms
Published 6 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Wakefield sues BMJ over MMR articles (5 responses)
Published 10 Jan 2012
Why legislation is necessary for my health reforms (5 responses)
Published 1 Feb 2012
Scientific misconduct is worryingly prevalent in the UK, shows BMJ survey (4 responses)
Published 12 Jan 2012